Pegylation of biologics

BioProcess International

Volumn 11, Issue 3, 2013, Pages 34-43

  Kling, Jim ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ASPARAGINASE MACROGOL; BIOLOGICAL PRODUCT; CERTOLIZUMAB PEGOL; CONTINUOUS ERYTHROPOIESIS RECEPTOR ACTIVATOR; EXCIPIENT; LYSINE; MACROGOL; PEGADEMASE; PEGAPTANIB; PEGINESATIDE; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; PEGLOTICASE; PEGVISOMANT; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; WATER;

ACROMEGALY; ACUTE LYMPHOBLASTIC LEUKEMIA; ANEMIA; ARTICLE; BIOPROCESS; CHEMICAL MODIFICATION; CHRONIC KIDNEY DISEASE; CREAM; CROHN DISEASE; DENDRITIC CELL; DRUG CLEARANCE; DRUG FORMULATION; DRUG HALF LIFE; DRUG MANUFACTURE; DRUG SOLUBILITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME METABOLISM; GOUT; HEPATITIS B; HEPATITIS C; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; KIDNEY CELL; KIDNEY CLEARANCE; NEUTROPENIA; PEGYLATION; POLYMERIZATION; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; RETINA MACULA AGE RELATED DEGENERATION; RHEUMATOID ARTHRITIS; SEVERE COMBINED IMMUNODEFICIENCY;

EID: 84876347198     PISSN: 15426319     EISSN: None     Source Type: Trade Journal    
DOI: None     Document Type: Article

References (20)

1. Crafts C. Poster: Analytical Methods to Qualify and Quantify PEG and PEGylated Biopharmaceuticals. Pittcon 2012, 12 March 2012; The Pittsburgh Conference: Pittsburgh, CA; www.pittcon.org.
2. Seyfried BK, et al. Microchip Capillary Gel Electrophoresis of Multiply PEGylated High-Molecular-Mass Glycoproteins. Biotechnol. J. 7(5) 2012: 635-641.
3. Hu G. PEGylating Peptides (and Proteins). BioProcess Int. 8(10) 2010: 40-41.
4. Richter AW, et al. Polyethylene Glycol Reactive Antibodies in Man: Titer Distribution in Allergic Patients Treated with Monomethoxy Polyethylene Glycol Modified Allergens or Placebo, and in Healthy Blood Donors. Int. Archs. Allergy Appl. Immun. 74, 1984: 36-39. (Pubitemid 14136479)
5. Armstrong JK, et al. Antibody Against Poly(Ethylene Glycol) Adversely Affects PEG-Asparaginase Therapy in Acute Lymphoblastic Leukemia Patients. Cancer 110, 2007: 103-111. (Pubitemid 46986423)
6. Press release: Highlights from BioMarin's Research and Development Day. BioMarin Pharmaceutical Inc.: Novato, CA, 8 December 2011.
7. Castillo B, et al. On the Relationship Between the Activity and Structure of PEG-α-chymotrypsin Conjugates in Organic Solvents. Biotechnol. Bioeng. 94, 2006: 565-574.
8. Inada Y, et al. Application of Polyethylene Glycol-Modified Enzymes in Biotechnology Processes: Organic Solvent-Soluble Enzymes. Trends Biotechnol. 4, 1986: 190-194. (Pubitemid 16059149)
9. DeSantis G, Jones JB. Chemical Modification of Enzymes for Enhanced Functionality. Curr. Opin. Biotechnol. 10, 1999: 324-330. (Pubitemid 29373944)
10. Veronese FM, et al. Pegylated Enzyme Entrapped in Poly(vinyl alcohol) Hydrogel for Biocatalytic Application. Farmaco 56, 2001: 541-547. (Pubitemid 32727924)
11. Schroeder M, et al. Chemical Modification of Proteases for Wool Cuticle Scale Removal. Biocatal. Biotransformation. 22, 2004: 299-305. (Pubitemid 40425612)
12. Schroeder M, et al. Restricting Detergent Protease Action to Surface of Protein Fibres by Chemical Modification. Appl. Microbiol. Biotechnol. 72, 2006: 738-744. (Pubitemid 44454935)
13. García-Arellano H, et al. High-Temperature Biocatalysis by Chemically Modified Cytochrome C. Bioconjug. Chem. 13, 2002: 1336-1344. (Pubitemid 35420028)
14. Santiago-Rodríguez L. et al. Enhanced Stability of a Nanostructured Cytochrome C Biosensor By PEGylation. J. Electroam. Chem. 663, 2011: 1-7.
15. Dattelbaum AM, et al. PEGylation of a Maltose Biosensor Promotes Enhanced Signal Response When Immobilized in a Silica Sol-Gel. Bioconjug. Chem. 20, 2009: 2381-2384.
16. González-Valdez J, et al. Advances and Trends in the Design, Analysis, and Characterization of Polymer-Protein Conjugates for "PEGylaided" Bioprocesses. Anal. Bioanal. Chem. 403, 2012: 2225-2235.
17. Tom I. Reproducible Production of a PEGylated Dual-Acting Peptide for Diabetes. AAPS J. 9, 2009: E227-E234.
18. Walsh S, et al. Improved Pharmacokinetics and Reduced Antibody Reactivity of Lysostaphin Conjugated to Polyethylene Glycol. Antimicrob. Agents Chemother. 47, 2003: 554-558. (Pubitemid 36158081)
19. Scott MD, et al. Beyond the Red Cell: Pegylation of Other Blood Cells and Tissues. Transfus. Clin. Biol. 11, 2004: 40-46. (Pubitemid 38230190)
20. Kenan DJ. Peptide-PEG Amphiphiles As Cytophobic Coatings for Mammalian and Bacterial Cells. Chem. Biol. 13, 2006: 695-700. (Pubitemid 44093294)